Publicaciones en colaboración con investigadores/as de Charité (14)

2024

  1. ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 35, Núm. 3, pp. 248-266

  2. Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer

    Bulletin du Cancer, Vol. 111, Núm. 3, pp. 277-284

2023

  1. Outcomes of Gynecologic Cancer Surgery During the COVID-19 Pandemic: An International, Multicenter, Prospective CovidSurg-Gynecologic Oncology Cancer Study

    Obstetrical and Gynecological Survey

  2. Social media ambassadors and collaboration with OncoAlert: A European Network of Young Gynae Oncologists study of comparative Twitter analysis of #ESGO2021 and #ESGO2022

    International Journal of Gynecological Cancer, Vol. 33, Núm. 6, pp. 964-970

2022

  1. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study

    American Journal of Obstetrics and Gynecology, Vol. 227, Núm. 5, pp. 735.e1-735.e25

2021

  1. European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery

    International Journal of Gynecological Cancer, Vol. 31, Núm. 9, pp. 1199-1206

  2. Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

    Cancer Medicine, Vol. 10, Núm. 1, pp. 208-219

  3. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

    British Journal of Surgery, Vol. 108, Núm. 1, pp. 88-96

2019

  1. Oncological outcome of surgical management in patients with recurrent uterine cancer - A multicenter retrospective cohort study - CEEGOG EX01 Trial

    International Journal of Gynecological Cancer, Vol. 29, Núm. 4, pp. 711-720

2018

  1. HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?

    Annals of Oncology

  2. Is there a role for HIPEC in ovarian cancer?

    Archives of Gynecology and Obstetrics

2017

  1. Brief Report about the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer from Spiliotis et al

    International Journal of Gynecological Cancer, Vol. 27, Núm. 2, pp. 246-247

  2. Value of neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer: A European perspective

    Journal of Clinical Oncology

2016

  1. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

    Annals of Oncology, Vol. 27, Núm. 1, pp. 16-41